OneMedNet Corporation (NASDAQ:ONMD) Short Interest Up 65.8% in January

OneMedNet Corporation (NASDAQ:ONMD) was the recipient of a significant increase in short interest in January. As of January 30th, there was short interest totaling 224,270 shares, an increase of 65.8% from the January 15th total of 135,229 shares. Currently, 0.8% of the company’s stock are short sold. Based on an average trading volume of 313,084 shares, the days-to-cover ratio is presently 0.7 days. Based on an average trading volume of 313,084 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.8% of the company’s stock are short sold.

Insiders Place Their Bets

In other OneMedNet news, CEO Aaron Green sold 61,555 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $1.20, for a total transaction of $73,866.00. Following the completion of the transaction, the chief executive officer owned 1,804,103 shares in the company, valued at $2,164,923.60. The trade was a 3.30% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 46.20% of the stock is currently owned by company insiders.

Institutional Trading of OneMedNet

Large investors have recently made changes to their positions in the company. Ashton Thomas Private Wealth LLC purchased a new position in OneMedNet during the 3rd quarter worth approximately $25,000. HRT Financial LP purchased a new position in shares of OneMedNet during the fourth quarter worth approximately $32,000. Jane Street Group LLC acquired a new position in shares of OneMedNet in the 4th quarter valued at $119,000. State Street Corp raised its position in OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after purchasing an additional 34,200 shares during the last quarter. Finally, Exencial Wealth Advisors LLC raised its position in OneMedNet by 3.1% in the 2nd quarter. Exencial Wealth Advisors LLC now owns 1,491,862 shares of the company’s stock valued at $851,000 after purchasing an additional 45,448 shares during the last quarter. 0.95% of the stock is owned by institutional investors and hedge funds.

OneMedNet Price Performance

Shares of NASDAQ:ONMD traded down $0.05 during trading on Friday, hitting $0.65. 419,431 shares of the company were exchanged, compared to its average volume of 281,247. The firm’s 50 day moving average price is $1.09 and its 200-day moving average price is $1.26. OneMedNet has a 12-month low of $0.30 and a 12-month high of $4.22. The stock has a market capitalization of $32.95 million, a P/E ratio of -12.92 and a beta of 1.13.

OneMedNet (NASDAQ:ONMD) last announced its quarterly earnings results on Friday, November 14th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.18 million for the quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of OneMedNet in a research note on Friday, January 9th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.